ML
Mollie Leoni (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kura Oncology, Inc. (KURA). The largest single filing was $834K of KURA (84,929 sh × $9.82, as filed), executed Jun 18. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Sep 29
Filed Sep 29
Median ADV $20.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
KURA
Kura Oncology, Inc.
KURA · 0 buys · 4 sells
4 filings
Recent filings
KURASALE
Kura Oncology, Inc.
View filing →
$440K41,250 sh across 2 lots
Exec Sep 28
Filed Sep 29 · 6:30 PM ET KURASALE Kura Oncology, Inc. View filing → $834K
84,929 sh × $9.82
Exec Jun 18
Filed Jun 22 · 5:30 PM ET KURASALE Kura Oncology, Inc. View filing → $173K
15,485 sh × $11.18
Exec Nov 14 2025
Filed Nov 14 2025 · 5:30 PM ET KURASALE Kura Oncology, Inc. View filing → $110K
12,314 sh × $8.94
Exec Sep 29 2025
Filed Sep 29 2025 · 5:30 PM ET